Citrix Options Shadow VMWare Earnings (CTXS, VMW)
VMWare Inc. (NYSE: VMW) soared in after-hours trading, and in our earnings summary we already noted that that this sets a very high bar for Citrix Systems Inc. (NASDAQ: CTXS) as a result of the strong virtualization market. We did not see this options trading in our reviews throughout the trading day, but it turns [...]
Apple Preview… Stock/Options Volume Spike (AAPL)
Apple Inc. (NASDAQ: AAPL) reports after today’s close and this will be the highlight of the earnings after Monday’s closing bell. Thomson Reuters has estimates pegged at $2.07 EPS (non-GAAP of course) and revenues of $12.06 billion… Whispers are significantly higher. Analysts are close to $240 in price targets, options traders are braced for a [...]
CIENA Runs on Analyst Initiation (CIEN)
CIENA Corporation (NASDAQ: CIEN) is trading up this morning on an analyst call. Auriga gave it a Buy rating with an $18 target. The firm has said that the transformational acquisition of Nortel’s metro-ethernet operations is off to a good start. Shares closed at $12.24 Friday, and shares are up at $12.68 on 25,250 per-market [...]
DryShips Running on Analyst Call (DRYS)
DryShips Inc. (NASDAQ: DRYS) is rallying with the market and also on an analyst upgrade. The stock of the shipper was raised to Buy from Hold over at Cantor Fitzgerald as part of a sector ratings change. At 8:53 AM EST we have shares trading up almost 5% at $6.11 on 687,000 shares. The 52-week [...]
Poniard Analyst Trumps Colorectal Cancer Study News (PARD)
Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) is down despite what appears to be some positive internal news. Its Phase 2 trial of picoplatin in metastatic colorectal cancer patients met its primary objective as picoplatin in combination with a FOLPI regimen was associated with a statistically significant reduction in neurotoxicity when the results were compared to oxaliplatin [...]
Keryx Showing Positive Colon Cancer Trials (KERX)
Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) is surging after the company reported updated results KRX-0401 as its PI3K/Akt pathway inhibitor for cancer as a combination with Xeloda as a treatment for advanced, metastatic colon cancer. The P-CAP arm showed a statistically significant advantage for TTP and OS and for the percentage of patients achieving Stable Disease [...]
Pacific Ethanol Trending Higher (PEIX)
Pacific Ethanol, Inc. (NASDAQ: PEIX) is trading higher this morning after continued news on Friday calling for improving conditions for ethanol producers. At 8:34 AM EST we have shares up 7% at $2.17 on almost 27,000 shares. The 52-week trading range is $0.20 to $2.75 and average volume is 3.6 million shares. Ethanol stocks have [...]
VS Investor RSS Feed